A Clinical Study to Evaluate the Efficacy of a Nutritional Supplement to Improve Carotenoid Content as Measured by a Non-invasive Hyperspectral Absorption Device

Pharmanex

Status

Completed

Conditions

Nutrition Assessment

Treatments

Dietary Supplement: LifePak Optimum nutritional supplement

Dietary Supplement: Placebo supplement

Study type

Interventional

Funder types

Other

Industry

Identifiers

NCT07380438

25-K540049EPE

Details and patient eligibility

About

The goal of this clinical trial is to evaluate a nutritional supplement in an otherwise healthy adult population. The main questions it aims to answer are:

Do antioxidant carotenoid levels increase in after supplementation as measured by a non-invasive device?
Do wellness factors correlate with supplementation?

Researchers will compare the nutritional supplement arm to a placebo group to assess its effects.

Participants will take either the nutritional supplement or placebo once daily for 8 weeks. Participants will be scanned by a non-invasive hyperspectral absorption device to obtain a skin carotenoid score. Participants will also have facial images taken, dermal spectrophotometry measurements of their face, and complete self-assessment questionnaires.

Enrollment

84 patients

Sex

All

Ages

20 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Aged 20-60 years.
all skin types
BMI between 18.5-23
No allergy with carotenoid-containing supplements

Exclusion criteria

subject who have undergone organ excision, organ transplantation, or experienced a skull concussion with extended loss of consciousness in the past 5 years, or with current after effects.
subjects with diseases such as heart disease, myocardial infarction, cancer, tuberculosis, chronic or acute renal failure, poliomyelitis, arthritis, or asthma
Subjects undergoing or schedule for long-term treatment, particularly with anti-inflammatory agents, steroids, sedatives, diabetes treatments, medications for blood pressure, hormone therapies, antihistamines, and/or drugs with similar functions,
subjects who have taken contraceptives or herbal medicines continuously for more than 2 months within the past 3 weeks,
subjects with any current medical condition, including gynecological disorders, or those undergoing hospital treatment,
subjects with known allergies to aspirin, antibiotics, fruits, laboratory substances, sunlight or metals;
Subjects who experience herpes outbreaks more than five times a year or suffer from acute swelling of the skin or mucous membranes;
Subjects with a history of psychiatric disorders, including sleep disorders or panic disorder